Determination and analysis of changes in the hepatobiliary system in patients with COVID-19

Bafoeva, Zarnigor; Sobirova, Guzal

dc.contributor.author	Bafoeva, Zarnigor
dc.contributor.author	Sobirova, Guzal
dc.date.accessioned	2021-12-29T15:32:22Z
dc.date.available	2021-12-29T15:32:22Z
dc.date.issued	2021-02
dc.identifier.issn	2165-9036
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/1292
dc.description.abstract	We retrospectively examined the medical history of 685 patients (25-90 years old) hospitalized with a diagnosis of coronavirus in the 2nd clinic of the Tashkent Medical Academy. Data obtained (age, sex, comorbidities, days of hospital treatment, laboratory parameters), mainly patients with changes in the hepatobiliary system (those with increased levels of alanine transferase and aspartate aminotransferase enzymes) were selected and statistically analyzed. Our statistical analysis revealed an increase in alanine transferase and aspartate aminotransferase enzymes in 182 patients, mainly men, middle-aged (44-60 years), and those with severe disease.	en_US
dc.language.iso	en	en_US
dc.relation.ispartofseries	21(2);145-147
dc.subject	COVID-19, Liver, ALT, AST	en_US
dc.title	Determination and analysis of changes in the hepatobiliary system in patients with COVID-19	en_US
dc.type	Article	en_US